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A significant portion of the genome is transcribed as
long noncoding RNAs (lncRNAs), several of which
are known to control gene expression. The repertoire
and regulation of lncRNAs in disease-relevant tis-
sues, however, has not been systematically explored.
We report a comprehensive strand-specific tran-
scriptomemapofhumanpancreatic isletsandbcells,
and uncover >1100 intergenic and antisense islet-cell
lncRNA genes.We find islet lncRNAs that are dynam-
ically regulated and show that they are an integral
component of the b cell differentiation and matura-
tion program. We sequenced the mouse islet tran-
scriptome and identify lncRNA orthologs that are
regulated like their human counterparts. Depletion
of HI-LNC25, a b cell-specific lncRNA, downregu-
lated GLIS3mRNA, thus exemplifying a gene regula-
tory function of islet lncRNAs. Finally, selected isletCelllncRNAs were dysregulated in type 2 diabetes or
mapped to genetic loci underlying diabetes suscepti-
bility. These findings reveal a new class of islet-cell
genes relevant to b cell programming and diabetes
pathophysiology.
INTRODUCTION
During recent years, it has become apparent that the genomes of
species as diverse as zebrafish, mice, and humans transcribe
thousands of RNAs that do not encode for proteins (Bertone
et al., 2004; Birney et al., 2007; Carninci et al., 2005; Guttman
et al., 2009; Ulitsky et al., 2011). A subset of noncoding tran-
scripts are larger than 200 nucleotides and are known as long
noncoding RNAs (lncRNAs) (Mattick and Makunin, 2006). The
function of most lncRNAs remains unknown. However, several
dozen lncRNAs are known to exert nonredundant roles in pro-
cesses such as X inactivation, imprinting, splicing, transcrip-
tional regulation, pluripotency, cancer, cell cycle, or survivalMetabolism 16, 435–448, October 3, 2012 ª2012 Elsevier Inc. 435
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Cell-Type Specific Human and Mouse Islet lncRNAs(Gupta et al., 2010; Guttman et al., 2011; Hu et al., 2011; Penny
et al., 1996; Rinn et al., 2007; Sleutels et al., 2002). In one ex-
ample, a lncRNA has been shown to promote reprogramming
of pluripotent cells from somatic cells (Loewer et al., 2010). Avail-
able evidence thus indicates that lncRNAs represent a still poorly
understood layer of gene regulation.
Numerous mammalian lncRNAs are expressed in a cell-type
specificmanner (Cabili et al., 2011;Mercer et al., 2008). Together
with knowledge that several such transcripts are functional, this
raises the intriguing possibility that lncRNAs could be previously
unsuspected mediators of lineage-specific differentiation or
specialized cellular functions. Defects in lncRNAs could thus
underlie human disease, and cell-specific regulatory lncRNAs
might provide therapeutic targets. This warrants the need to
explore the repertoires of lncRNAs of disease-relevant cell types
and tissues.
Pancreatic islets of Langerhans are an excellent model of
a specialized tissue that is closely linked to human disease. Islets
comprise insulin-secreting b cells and other polypeptide
hormone-producing cells, including glucagon-secreting a-cells.
Islet-cell dysfunction is central to the pathophysiology of type
2 diabetes (T2D), the most prevalent form of diabetes (Bell and
Polonsky, 2001). Recent genome-wide association studies
for T2D and related traits have revealed >50 susceptibility
loci, most of which are not known to carry variants that alter
protein-coding sequences (McCarthy, 2010). A common hy-
pothesis is that such variants impact regulatory elements of
protein-coding genes, although they could equally affect other
non-protein-coding elements such as lncRNAs.
In type 1 diabetes, b cells are destroyed by autoimmune
mechanisms, and consequently several experimental appro-
aches are being developed to replace destroyed cells (Halban
et al., 2001). One approach is based on the recent discovery of
b cell transcription factors, some of which have been misex-
pressed in somatic cells to create insulin-expressing cells
(Collombat et al., 2009; Zhou et al., 2008). Another approach is
to derive b cells from pluripotent cells (Kroon et al., 2008).
However, existing strategies have not yet succeeded in gener-
ating fully functional therapeutic b cells in vitro. Clearly, the
identification of novel regulators of b cell differentiation and
maturation remains a major challenge, and islet-specific regula-
tory transcripts are logical targets for this effort. Despite the
potential implications for human diabetes, information on islet-
cell lncRNAs is lacking.
In this study, we integrated sequence-based transcriptome
and chromatin maps of human islets and b cells to define 1128
islet lncRNA genes. We show that these lncRNAs are an integral
component of the dynamic b cell-specific differentiation pro-
gram, suggesting a role as biomarkers and potential regulators
for programming efforts. We extend existing knowledge on
lncRNAs by disclosing orthologous mouse transcripts that are
regulated in an evolutionarily conserved manner. We focused
on one islet-specific lncRNA and show that it impacts the
expression of a regulatory target. Finally, we show dysregulation
of islet lncRNAs in T2D andmap selected lncRNAs to human dia-
betes genetic susceptibility loci. Collectively, these studies
describe a new class of islet genes and provide diverse lines of
evidence to suggest that islet lncRNAs may impact diabetes
pathophysiology and efforts to program therapeutic b cells.436 Cell Metabolism 16, 435–448, October 3, 2012 ª2012 Elsevier InRESULTS
High-Resolution Maps of Active Human Pancreatic Islet
Cell Genes
To identify human b cell lncRNAs we integrated transcriptional
and chromatin maps of purified human islet cells (Figure 1A).
We generated directional and nondirectional cDNA libraries
from PolyA+ and Ribo RNA fractions of six human islets and
two FACS-purified b cell samples, and we collected >460 million
uniquely mapped paired-end sequence reads (Table S1). To
increase our ability to define the structure of novel genes, we
mapped epigenetic gene landmarks in three human islet
samples, including H3K4me3, which is enriched in active pro-
moter regions (Table S1). These data sets were then integrated
to build strand-specific models of active human islet-cell genes
with their predominant splicing patterns (Figure 1A).
As a measure of quality, we first examined annotated genes
and recovered 70% as expressed above a threshold level of
0.5 reads per million mapped reads (RPKM) in islet cells. Despite
the fact that the samples originated from diverse human islet
donors (Table S2), both mRNA and H3K4me3 levels showed
a high correlation between the different human islet samples
(r2 > 0.94; Figures S1A and S1B). Consistent with the high islet
purity, the most abundant H3K4me3-positive transcripts in-
cluded known islet-cell and bcell genes (Figure 1B, Table S3).
Remarkably,20% of exonic reads in islets and45% in b cells
originated from the Proinsulin mRNA (Figure 1B). Moreover,
known islet-specific genes displayed coherent chromatin
enrichment patterns (see, for example, Figures 1C and S1C).
Genomic inventories of human islets are unavoidably con-
founded by signals from contaminant exocrine cells. Our
approach, however, allowed us to define lncRNAs that are truly
expressed in b cells and other islet cell types. Transcripts from
few contaminating acinar cells were efficiently excluded
because they lacked H3K4me3 enrichment in islet preparations
(Figures S1D and S1H, Table S3). Accordingly, <1% of genes
that we defined as active in islet cells were contaminant acinar
transcripts, on the basis of a relative enrichment in acinar versus
islet-cell RNA. This initial analysis thus validated our strategy to
map bona-fide active genes in human islets and b cells.
Human Islet Cells Transcribe Intergenic and Antisense
lncRNAs
Over 19% of the transcribed genome in human islets mapped
outside of annotated protein-coding genes (Figure S1E). To
define discrete islet-cell lncRNA genes, we selected 1128 tran-
scripts with the following properties: (1) length >200 bp; (2)
H3K4me3 enrichment in a coherent location relative to the tran-
scribed strand; (3) expression >0.5 RPKM in all five islet and
b cell PolyA+ samples; (4) no splicing or overlap with any coding
gene present in RefSeq, UCSC, or Ensembl annotations; and (5)
low protein-coding potential. Of these, 761 were ‘‘antisense’’
(AS) lncRNAs, located <1 kb from an annotated gene but in
a divergent orientation (Figure 1D). Thirty-two were <1 kb from
an annotated gene but in a convergent orientation. Another set
of 335 were ‘‘intergenic’’ (IG) lncRNAs, located >1 kb from any
coding gene. Finally, we identified 55 annotated lncRNAs that
were located within the boundaries of coding genes and
termed these ‘‘overlapping antisense’’ lncRNAs (Figure 1D).c.
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Figure 1. Systematic Identification of Human Islet and b cell lncRNAs
(A) Outline of the analysis pipeline.
(B) RNA-seq expression levels in the three pancreatic cell fractions for the ten most-expressed H3K4me3-positive genes in human islets.
(C) Chromatin and RNA-seq landscape of the INS locus.
(D) Definitions and counts of different lncRNA classes.
(E) Kernel density plot of the codon substitution rate of islet lncRNAs (red), intergenic control regions (black) and randomly selected exons of protein-coding genes
(green).
(F) Kernel density plot of the transcriptional abundance of all RefSeq genes (green), intergenic (red), and antisense (orange) lncRNAs. The dashed line marks the
0.5 RPKM expression threshold used for defining lncRNAs. See also Figure S1 and Tables S1–S5.
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Cell-Type Specific Human and Mouse Islet lncRNAsFor subsequent analysis we merged convergent and intergenic
lncRNAs (a total of 367) as neither was closely associated with
a promoter of a protein-coding gene. Comparison with acinar
RNA-seq showed that only one lncRNA showed >3-fold acinar
enrichment. Furthermore, qPCR analysis confirmed expression
of 31/31 lncRNAs in human islets, and 26/31 in the human
b cell-line EndoC-b H1 (Ravassard et al., 2011) (data not shown).
These transcripts are therefore bona-fide islet-cell and in most
cases b cell lncRNAs. Their genomic location and exon annota-
tions are provided in Table S4.
Further analysis of the genomic properties of the 1128 islet
lncRNAs showed that their overall protein-coding parameters
resembled those of randomly chosen intergenic regions, con-
firming that most are likely to be truly noncoding transcripts
(Figures 1E and S1F). Antisense and intergenic lncRNAs had
a similar average length as RefSeq genes, yet showed
10-fold lower expression (Figure 1F). Despite the low abun-
dance of lncRNAs, the top quartile were expressed at levels
comparable to mRNAs encoding transcriptional regulators
linked to human diabetes (HNF1A, HNF4A, and TCF7L2; 6.4,
7.1 and 5.7 RPKM in human islets, respectively). ComparedCellwith RefSeq transcripts, islet lncRNA genes displayed similar
RNA Pol II enrichment but were less often H3K36me3 enriched,
in keeping with less frequent splicing (36% for intergenic
lncRNAs, versus 93% in RefSeq genes) (Table S5). Finally,
lncRNAs overlapped interspersed repeat regions more often
than coding exons, yet less than random intergenic control
regions (Figure S1G). In conclusion, these studies uncover
a high-confidence set of 1128 human islet-cell genes that have
several expected properties for lncRNAs.
Islet lncRNAs Are Highly Tissue Specific
Because many islet lncRNAs have escaped annotation, we
reasoned that this could be in part because this class of tran-
scripts is often cell-type specific. We realigned 16 human non-
pancreatic RNA-seq data sets (Table S1), and found that 9.4%
of RefSeq annotated genes were islet specific (Figure 2A,
Table S6; see Experimental Procedures for a definition of the
islet-specificity score). By contrast, 55% of intergenic lncRNAs,
and 40% of antisense islet lncRNAs were islet specific, a signifi-
cant enrichment over protein-coding genes (p < 3$1016 for both
comparisons) (Figure 2B). This set of lncRNAs was similarlyMetabolism 16, 435–448, October 3, 2012 ª2012 Elsevier Inc. 437
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Figure 2. Islet lncRNAs Are Highly Tissue Specific
(A) Hierarchical clustering of expression levels of all RefSeq genes (left) and lncRNAs (right) across human islets, FACS-purified b cells and 16 nonpancreatic
human tissues. Bottom panels highlight islet-specific transcripts in green.
(B) Islet specificity of antisense and intergenic lncRNAs compared to all RefSeq genes. P values were calculated by Chi-Square test.
(C) Representative examples of islet-enriched lncRNAs. Gene models are depicted in red and transcript orientation with a red arrow. All rows depict RNA-seq
except the top row, which shows consistent peaks for H3K4me3 (green), H3K36 (yellow), and RNA Polymerase II (gray). The vertical axis is scaled at the same
expression level for all tissues. Only 5/16 representative nonpancreatic tissues are shown for simplicity. See also Figure S2 and Table S6.
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Cell-Type Specific Human and Mouse Islet lncRNAsenriched in purified b cells (Figure 2A and not shown). Many
examples of lncRNAs were thus found to be unique or highly
specific to b cells within the entire panel of 18 tissues (Figure 2C).
The islet selectivity was confirmed by qPCR in 12/12 lncRNAs
using an independent panel of nine tissues (Figure S2). Thus,
human islet-cell lncRNAs are frequently transcribed in a highly
cell-type specific manner.
Islet lncRNAs Often Map near Islet-Specific Chromatin
Domains and Coding Genes
To explore the biological significance of human islet lncRNAs, we
next examined their relationship with nearby protein-coding
genes. The abundance of each lncRNA transcript in human islets
was not related to that of the neighboring protein-coding mRNA
(Figure S3A). However, the expression of lncRNAs and their most
proximal protein-coding gene significantly correlated across
different tissues (p < 3$1014) (Figure 3A). Accordingly, the
closest protein-coding genes to islet intergenic and antisense
lncRNAs were more often islet-specific than the entire collection
of annotated genes (p < 1010), up to >3-fold when considering
only islet-specific lncRNAs (p < 2$1011) (Figures 3B and 3C).
Notably, islet lncRNAs were preferentially located in genomic
regions where the closest protein-coding gene has been linked438 Cell Metabolism 16, 435–448, October 3, 2012 ª2012 Elsevier Into b cell function, development, and transcription (Figure 3C).
Examples of known islet protein-coding genes paired with
intergenic lncRNAs include MAFB, FOXA2, PCSK1, and ISL1
(Figure S3B and data not shown). We compiled a list of 20 genes
encoding known islet-enriched transcription factors, and found
that remarkably 13 (65%), including HNF1A, PDX1, PAX6,
ISL1, INSM1, NEUROD1, GATA6, NKX2-2, and RFX6, were
associated with antisense lncRNAs (Figure S3B and data not
shown). Thus, islet lncRNAs often map to the same genomic
region as islet-enriched protein-coding genes.
It was also apparent that lncRNAs were often located in gene-
poor areas. We examined the genomic intergenic spaces where
lncRNAs reside and found that they are on average nearly 3-fold
larger than the entire set of intergenic intervals in the human
genome (p < 3$1012) (Figure 3D). The fact that islet lncRNAs
were often located in large gene-poor spaces, yet associated
to genes with similar cell-type specific expression, suggested
the existence of broad cell-specific regulatory domains. Human
islets harbor tissue-specific clusters of open chromatin regula-
tory elements (COREs), often linked to a single islet-enriched
protein-coding gene (Gaulton et al., 2010). We thus examined
the relationship of islet lncRNAs to islet-specific COREs (see
Experimental Procedures). Both intergenic and antisensec.
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Cell-Type Specific Human and Mouse Islet lncRNAslncRNAs, as well as their nearby annotated genes, were more
often located near islet-selective COREs than random intergenic
regions (p < 3$109) or expressed annotated genes (p < 0.013)
(Figure 3E). Thus, islet lncRNAs are often associated to broad
cell-specific regulatory domains, many of which appear to be
shared by protein-coding genes.
HI-LNC25 illustrates many of the above-mentioned features. It
is a multiexonic transcript located in a broad1.6 Mb space that
lacks any protein-coding gene but contains clusters of islet-
specific active chromatin (Figure 3F). The most proximal
protein-coding gene is MAFB, an essential regulator of islet-
cell maturation that is abundantly expressed in human b cells
(Artner et al., 2007; Dorrell et al., 2011). Interestingly, whereas
MAFB is expressed in several tissues, HI-LNC25 shows a
much more restricted tissue distribution (Figure 3F). Taken
together, these results indicate that islet-selective lncRNAs are
frequently associated with cell-specific higher-order chromatin
domains that potentially underlie coregulation of noncoding
and coding transcript pairs.
Stage-Specific Activation of lncRNAs during b Cell
Maturation
To understand the developmental regulation of islet lncRNAs, we
first used qPCR to test the expression of b cell selective lncRNAs
(ten intergenic, three antisense) in dissected Carnegie stage
17–19 human embryonic pancreas, a progenitor stage that
shows scarce signs of cytodifferentiation (Piper et al., 2004). Of
the 13 lncRNAs that were examined, all except one were silent
or expressed at low levels in pancreatic progenitors and were
subsequently active in adult islets (Figure 4A). Thus, islet
lncRNAs are not only often islet specific, but they are also linked
to the pancreatic endocrine differentiation program.
We next examined the dynamics of islet lncRNAs in a human
embryonic stem-cell (hES) differentiation model. Current
methods to differentiate b cells from stem cells are limited by
difficulties in completing the maturation of b cells in vitro. We
thus used a hES cell protocol that involves multiple in vitro
differentiation steps, followed by encapsulation of differentiated
pancreatic endoderm, which after implantation into mice pro-
duces mature endocrine cells over a 140 day in vivo incuba-
tion period (Kroon et al., 2008). We profiled the same lncRNAs
at each stage of the protocol and discovered that all islet
lncRNAs were markedly induced during the in vivo maturation
step (Figure 4B). Notably, six lncRNAs were expressed at very
low or undetectable levels throughout all in vitro differentiation
steps and were only activated during the in vivo maturation
step (Figure 4B). Thus, islet-specific lncRNA gene activation
is linked to pancreatic endocrine differentiation during em-
bryogenesis and during in vivo differentiation of hES cell-
derived pancreatic progenitors. Islet lncRNAs are therefore
candidate markers and/or regulators of b cell differentiation
and maturation.
Glucose-Dependent Regulation of Islet lncRNAs
Mature b cells exhibit a transcriptional response to increased
demand (Bensellam et al., 2009; Schuit et al., 2002). Selected
islet protein-coding transcripts are thus moderately induced in
response to high glucose under appropriate experimental con-
ditions. To assess if islet lncRNAs are also dynamically regu-Celllated, we exposed human islets to 4 mM or 11 mM glucose for
72 hrs. This revealed glucose-dependent changes in protein-
coding mRNAs related to insulin secretion (INS, IAPP, PCSK1),
whereas the stress-responsive marker DDIT3 (CHOP) was not
induced (Figure 4C). We then tested the set of 13 islet lncRNAs
and discovered that HI-LNC78 and HI-LNC80, two intergenic
multiexonic lncRNAs that are not located near islet-enriched
protein coding genes, were consistently upregulated in a
glucose-dependent manner in five individual donors (Figure 4C).
Thus, selected islet lncRNAs are dynamically regulated in
settings that are relevant for mature islet-cell physiology.
Identification of Conserved b Cell-Specific lncRNAs
in Mice
We next assessed the evolutionary conservation of islet
lncRNAs. Mammalian sequence conservation scores of islet
lncRNAs were markedly lower than protein-coding exons, yet
higher than random intergenic regions, in keeping with previous
results (Pauli et al., 2012; Ulitsky et al., 2011) (Figure 5A). For
nearly 70% of human lncRNAs, we identified orthologous mouse
genomic regions of >200 bp, compared to 58% of random
human intergenic regions (p < 2$109) (Figure 5B).
The degree of sequence identity that is required for functional
conservation of noncoding transcripts is uncertain. To improve
our understanding of the evolutionary conservation of islet
lncRNAs, we examined if orthologous lncRNAs were transcribed
in mouse islets. To this end, we generated 78 million paired-end
reads from purified mouse islet PolyA+ RNA directional libraries
(Table S7). We found that 47%of themouse orthologous regions
were transcribed in mouse islets, as opposed to <3% random
intergenic regions of the same size (p < 3$1016) (Figure 5C).
This is likely an underestimate of orthologous mouse lncRNAs
since qPCR analysis confirmed the expression of 7/7 ortholo-
gous mouse lncRNAs, and it also showed that 5/7 orthologous
mouse genomic regions that did not surpass our detection
threshold in the RNA-seq analysis were nevertheless detected
at low levels in mouse islet and/or b cell-line RNA, whereas con-
trol intergenic regions were undetectable (Figures 5D and 5E).
Next, we assessed if mouse orthologous lncRNA tran-
scripts are regulated in a similar manner as their human counter-
parts. Like human lncRNAs, mouse orthologous transcripts
were >4-fold more frequently islet-cell-specific than protein-
coding genes (p < 3$1016) (Figures 5F, 5G, and S4A). Moreover,
the analysis of E13.5 embryonic pancreas showed that five out
eight lncRNAs were inactive prior to endocrine differentiation,
indicating that they are typically regulated in a similar stage-
specific fashion as their human orthologs (Figures 5H and
S4B). Furthermore, a comparison of islets from neonate and
adult mice showed that most lncRNAs were further upregulated
during postnatal islet maturation (Figure S4C). Likewise, five out
of eight tested mouse islet lncRNAs were induced upon expo-
sure to high-glucose concentrations, including Mi-Linc80,
whose ortholog is glucose-responsive in human islets (Figure 5I).
Several islet lncRNAs were also regulated in vivo in glucose in-
tolerant Leptin-deficient mice (Figure S4D). Thus, genomic
mouse regions that are orthologous to human islet lncRNA genes
are frequently also transcribed in islets, and like their human
counterparts they exhibit a highly dynamic and cell-specific
regulation.Metabolism 16, 435–448, October 3, 2012 ª2012 Elsevier Inc. 439
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F
Figure 3. Many Islet lncRNAs Map Near Islet-Specific Chromatin Domains and Regulatory Genes
(A) LncRNA transcript levels correlate with those of their nearest coding gene across tissues. Kernel density plots of correlation of RNA levels for random gene
pairs (green), intergenic (IG) lncRNAs paired with their nearest coding genes (red) (p < 3$1014 compared to random genes pairs, Mann-Whitney U test), and
antisense (AS) lncRNAs with their proximal coding genes (orange) (p < 3$1016).
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Figure 4. Human lncRNAs Are Dynamically
Regulated
(A) Expression of human islet-specific lncRNAs
(10 intergenic, 3 antisense) was assayed in mature
islets and pooled embryonic pancreas (Carnegie
stage 17–19) by qPCR. The results were normal-
ized to TBP mRNA and expressed as a fraction of
expression in islets. All but one lncRNAs were
activated after the pancreatic progenitor stage.
(B) Human islet lncRNAs are induced upon in vivo
differentiation of embryonic stem cells. Human
embryonic stem cells (ES) were subjected to
a differentiation protocol that undergoes stage-
specific differentiation to definitive endoderm (DE),
primitive gut tube (GT), foregut endoderm (FG),
and pancreatic endoderm (PE), respectively. The
cells are then transplanted into mice to allow for
in vivo maturation of functional endocrine cells
(FE). ES, DE, GT, FG, PE, and FE represent days 0,
2, 5, 7, 10, and 150 of the differentiation protocol.
HI-LNC65 was not detected in any of the matura-
tion steps and is not shown.
(C) Expression of a subset of human lncRNAs is
regulated by glucose. Human islets were either
cultured under low (4 mM) or high (11mM) glucose
concentrations for 72 hr. Panels from left to right
illustrate expected glucose responsiveness of INS,
IAPP, and PCSK1, and the glucose responsive-
ness of HI-LNC78 and HI-LNC80 in five indepen-
dent human islet samples. Values are normalized
to TBP mRNA and expressed as a fraction of the
condition denoted in the vertical axis label. Bars
represent means ± SEM and asterisks denote p <
0.001 (Student’s t test).
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The evolutionary conserved regulation of islet lncRNAs points to
a functional role. LncRNAs have been linked to diverse types of
functions, frequently involving direct or indirect regulation of
expression of protein-coding genes (Wang and Chang, 2011).(B) Islet specificity of all coding RefSeq genes (CDS) compared with the nearest coding RefSeq gene to islet-s
were calculated by Chi-square test.
(C) Top-enriched gene ontology terms for genes closest to islet-specific lncRNAs.
(D) LncRNAs are preferentially located in gene-poor regions. Violin plots of the length distribution of all intergen
intergenic spaces where antisense and intergenic lncRNAs reside.
(E) Percentage of islet-specific lncRNAs located near islet-specific clusters of regulatory elements (CORE
RefSeq genes. Dark gray areas of the bars represent lncRNAs directly overlapping a CORE element, while lig
located <100 kb away from COREs.
(F) Birds-eye view of a 2 Mb region surrounding the islet regulator MAFB, centered on HI-LNC25. All rows
except for the first four rows, which show the islet CORE regions (black), enriched regions for RNA polymera
The bottom inset shows a zoomed-in view of the HI-LNC25 gene. Only 8/16 representative human tissues a
Cell Metabolism 16, 435–448To begin to understand islet lncRNA func-
tion we focused on HI-LNC25, which
fulfills several typical features of human
islet lncRNAs, as shown in Figure 3F. As
an experimental model we used a human
b cell line (EndoC-b H1) that exhibits
glucose-induced insulin secretion (Rav-
assard et al., 2011). We transduced
human b cells with lentiviral vectors ex-
pressing two independent shRNA hair-
pins that suppressed HI-LNC25 RNAand examined the expression of a panel of 24 islet mRNAs.
This screen identified GLIS3 mRNA as a potential regulatory
target of HI-LNC25. GLIS3 encodes an islet transcription factor,
it is mutated in a form of monogenic diabetes, and contains T2D
risk variants (Cho et al., 2012; Sene´e et al., 2006). We thereforepecific antisense and intergenic lncRNAs. P values
ic spaces in the genome >1 kb, compared with the
s), compared with random intergenic regions and
ht gray areas represent non-overlapping lncRNAs
depict RNA-seq (vertical axis fixed at 50 RPKMs),
se II (gray), H3K36 (yellow), and H3K4me3 (green).
re shown for simplicity. See also Figure S3.
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Figure 5. Mouse Islet lncRNA Orthologs Exhibit Conserved Regulation
(A) Mean phastCons scores for intergenic lncRNAs (red), antisense lncRNAs (orange), random intergenic fragments (black), and coding genes (green).
(B) Fraction of human RefSeq exons, random intergenic regions, and lncRNAs with an orthologous mouse genomic region of at least 200 bp.
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Cell-Type Specific Human and Mouse Islet lncRNAsperformed four independent HI-LNC25 knockdown experiments
with two separate shRNA hairpins. Although this depletion of HI-
LNC25 did not cause significant changes in glucose-stimulated
insulin secretion (not shown), we observed a consistent re-
duction of GLIS3 mRNA in comparison to five control shRNA
hairpins, whereas other control genes remained unaltered (Fig-
ure 6A). This effect was stably maintained over several days in
culture (Figure 6B). Thus, HI-LNC25 positively regulates GLIS3
mRNA, supporting the notion that our collection of islet lncRNAs
contains regulatory transcripts.
Dysregulation of Islet lncRNAs in Human T2D
To determine the potential role of islet lncRNAs in the pathogen-
esis of diabetes, we first examined whether lncRNAs are abnor-
mally expressed in human islets from donors with T2D.
We examined the panel of 13 lncRNAs and addedKCNQ1OT1,
a lncRNA that was detected as an overlapping antisense lncRNA
in our analysis, and has been previously genetically associated
with T2D (Voight et al., 2010). We compared these lncRNAs in
islets from 19 nondiabetic and 16 T2D donors. We found that
two lncRNAs, namely KCNQ1OT1 and HI-LNC45, were sig-
nificantly increased or decreased in T2D islets, respectively
(p < 0.02) (Figure 7A). To ensure that this result was not due to
differences in islet purity between groups of samples, we nor-
malized the expression levels of HI-LNCs relative to the islet
transcription factor PAX6, and found similar results (data not
shown). Thus, selected lncRNAs are dysregulated in T2D islets.
A Subset of lncRNAs Map to Genomic Loci Underlying
Human Diabetes
To further examine the potential role of islet lncRNAs in the
genetic susceptibility for diabetes, we first examined loci impli-
cated in monogenic syndromes of b cell dysfunction disorders.
Islet antisense lncRNAs were found within loci underlying neo-
natal diabetes (ABCC8/KCNJ11), pancreas agenesis (GATA6),
and monogenic diabetes (HNF1A) (Allen et al., 2012; Bell and
Polonsky, 2001; Gloyn et al., 2004). Because several antisense
lncRNAs have been implicated in cis regulatory effects (Wilusz
et al., 2009; Xu et al., 2011), these islet lncRNAs provide addi-
tional candidate regulatory elements that may contain patho-
genic variants.
Next, we examined genetic association data from multifacto-
rial T2D and related continuous glycemic measures, including
fasting glucose in nondiabetic individuals (Dupuis et al., 2010;
Voight et al., 2010). Currently, >50 loci are known to show asso-
ciation to T2D and related traits, and at most loci noncoding vari-
ants are likely to be causal (McCarthy, 2010). Earlier studies(C) Fraction of orthologous regions to human RefSeq exons, random intergenic r
RNA-seq.
(D) qPCR confirmation in mouse islets and MIN6 mouse b cell line for 7/7 ortholo
(E) qPCR reveals islet expression of 4/7 orthologous regions where islet RNA-seq d
control reactions lacking reverse transcriptase.
(F) Orthologous mouse lncRNAs are more frequently islet specific than RefSeq g
(G) Examples of conserved mouse islet-specific lncRNAs. Red arrows depict lncR
(RPKM).
(H) qPCR shows that 4/7 lncRNAs were silent in E13.5 mouse embryonic pancre
(I) Expression of several orthologous lncRNAs is regulated by glucose.Mouse islet
for 72 hr. Expression is shown as a fraction of expression under low-glucose con
average ± SEM and asterisks denote p < 0.001 (Student’s t test). See also Figur
Cellshowed that two annotated lncRNAs, ANRIL/CDKN2BAS and
KCNQ1OT1, map within established T2D susceptibility loci
(Voight et al., 2010; Zeggini et al., 2007). To evaluate the potential
overlap between newly identified islet lncRNAs with T2D loci, we
used MAGENTA (Segre` et al., 2010). This tool tests whether
a prespecified set of genes is enriched for trait associations in
genome-wide data, and was applied here to available data
sets for T2D and related continuous glycemic measures, as
well as five nonislet related control phenotypes.
We found that islet lncRNA transcripts were, as a group, en-
riched for association with both T2D (p = 0.02) and fasting
glucose (p = 0.01), with no enrichment for the control phenotypes
apart from height (p = 0.02) (Lango Allen et al., 2010) and waist-
hip ratio (p = 0.001) (Heid et al., 2010). When lncRNAs were
examined by type (intergenic versus antisense), enrichment of
association signal for intergenic lncRNAs was only observed
for T2D and fasting glucose (T2D p = 0.03; fasting glucose p =
0.003) (Table S8). Of 55 T2D susceptibility loci, 9 contained islet
lncRNAs within 150 kb of the reported lead SNP, 6 of which have
been linked directly to b cell dysfunction (Figure 7A) (Cho et al.,
2012; Dupuis et al., 2010; Kooner et al., 2011; Strawbridge
et al., 2011; van de Bunt and Gloyn, 2010; Voight et al., 2010).
Examples include a lncRNA in the vicinity of PROX1, which over-
laps the region of strongest association, very likely to contain the
casual SNP (Figure 7B), and the most significant lncRNA in the
MAGENTA analysis, near WFS1 (Figure 7C). These studies
therefore offer a newclass of genomic elements that canbe inter-
rogated to dissect the functional etiology of T2D susceptibility.
DISCUSSION
Increasing evidence points to a regulatory function of many
lncRNAs, which suggests a pivotal role in physiology and dis-
ease (Guttman and Rinn, 2012; Wang and Chang, 2011). We
have integrated transcriptional and chromatin maps to system-
atically annotate lncRNA genes in pancreatic islet cells, a key
tissue for human diabetes. Strand-specific analysis uncovered
hundreds of intergenic islet lncRNAs and many others that
were antisense to protein-coding genes and hence not discern-
able using conventional cDNA libraries. Human islet lncRNAs
were found to be highly cell-type specific, developmentally regu-
lated, and tightly linked to the differentiation of ES cell-derived
islet cells. We identified mouse orthologous transcripts, and
discovered that they are dynamically regulated in a similar
manner as human islet lncRNAs. We focused on a prototypical
islet lncRNA and demonstrate that it acts as a positive re-
gulator of an islet mRNA. Finally, we show examples of lncRNAsegions, and lncRNAs that are transcribed higher than 0.5 RPKM in mouse islet
gous mouse islet lncRNAs.
id not reveal transcription, but not in random intergenic regions. NoRT denotes
enes.
NA orientation. The y axis for all tissues is adjusted to the same value as islets
as and were induced in adult islets.
s were cultured either under low (4mM) or high (11mM) glucose concentrations
ditions (n = 4). All qPCR values are normalized to Tbp mRNA. Bars represent
e S4 and Table S7.
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Figure 6. Knockdown of HI-LNC25 in b Cells Causes Downregula-
tion of GLIS3
(A) Human b cells (EndoC-b H1) were transduced with lentiviral vectors
expressing two independent RNA hairpins that target HI-LNC25 RNA or five
independently transduced negative control nontargeting shRNA sequences.
Cells were harvested at 7 days and assayed for GLIS3 mRNA and several
control genes.
(B) Effects on GLIS3 mRNA were stable 3–7 days post transduction. Expres-
sion levels were normalized to TBP mRNA and shown as a fraction of non-
targeting vector cells. The results reflect four independent experiments. Bars
are average ± SEM, p values were obtained with Student’s t test.
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Cell-Type Specific Human and Mouse Islet lncRNAsthat are dysregulated in T2D islets and others that map to T2D
susceptibility loci. These studies open new avenues to study
the role of functional lncRNAs in islet-cell disease and thera-
peutic programming.
LncRNAs Are Dynamically Regulated during Islet Cell
Maturation
Islet lncRNAs show a striking cell-type specific expression
pattern. This finding is in line with a recent analysis of intergenic
lncRNAs across multiple tissues (Pauli et al., 2012), and with
earlier descriptions of lncRNAs that have distinct cell-type
specific expression patterns in brain (Mercer et al., 2008). Our
studies additionally demonstrate that islet-specific lncRNA
genes are inactive in embryonic pancreatic progenitors and sub-
sequently become activated in islet cells. Likewise, numerous
lncRNAs were activated during the final endocrine differentiation
step of a pluripotent cell differentiation protocol. This indicates
that islet lncRNAs are an integral component of the endocrine
differentiation program.
Islet-specific lncRNA transcription was linked to clusters
of open chromatin. Such clusters were previously shown
to be associated with islet-specific transcription (Gaulton
et al., 2010). Interestingly, we also observed concordant cell-
specific transcription of lncRNAs with their nearest protein-
coding genes, in accordance with other genomic analysis of
lncRNAs (Ponjavic et al., 2009). These data suggest that
concordant tissue-specific expression of lncRNA and protein-
coding pairs is linked to shared chromosomal regulatory
domains.444 Cell Metabolism 16, 435–448, October 3, 2012 ª2012 Elsevier InThe islet specificity of lncRNAs is reminiscent of the recent
discovery of transcription factors that show a similar stage-
and cell-specific activation pattern (reviewed in Servitja and
Ferrer, 2004). Several such islet-enriched factors have now
been shown to control islet development and have consequently
been exploited to program insulin-expressing cells from somatic
cells (Collombat et al., 2009; Zhou et al., 2008). By analogy, islet
lncRNAs that exert gene-regulatory functions could also be em-
ployed in efforts to program functional b cells. This prospect is
supported by recent studies showing that a lncRNA can promote
reprogramming pluripotent cells from somatic cells (Loewer
et al., 2010).
Several islet lncRNAs were specifically activated during the
in vivo maturation step of the ES cell differentiation protocol.
This result is significant because the major roadblock for efforts
to derive fully functional b cells from pluripotent cells lies in the
inability to complete the differentiation process in vitro (Van
Hoof et al., 2009). Our findings suggest that lncRNAs that are
induced at this late stage can be used as biomarkers of mature
b cells and potentially be exploited as effectors to promote
b cell programming.
Evolutionary Conserved Regulation of Islet lncRNAs
For a major fraction of lncRNAs we identified orthologous mouse
genomic regions, although the overall sequence identity was
clearly not subject to a similar evolutionary constraint as
protein-coding genes, in keeping with earlier studies of lncRNAs
(Pauli et al., 2012; Ulitsky et al., 2011). Several mechanisms have
been previously proposed to explain this comparatively low
sequence conservation, including a hypothetically less stringent
requirement for primary sequence conservation to maintain
functional secondary structures, or the existence of very short
stretches of functional sequences (Ulitsky et al., 2011).
It is also conceivable that evolutionary changes in lncRNA
sequences are functionally coupled to other parallel genomic
changes, such as the acquisition of species-specific repetitive
elements.
Importantly, in the current study we discovered that a signifi-
cant fraction of orthologous mouse sequences were transcribed
in mouse islet cells and b cell lines. Orthologous lncRNA pairs
display similar cell-type specific expression and stage-specific
regulation during embryonic development. This finding points
to an evolutionary conserved functional property of lncRNAs
that extends beyond primary sequence and further supports
that lncRNAs are an integral component of the mammalian
islet-cell differentiated phenotype.
Islet lncRNAs and Diabetes
The identification of lncRNAs opens a new framework to study
human pathophysiology. Our study revealed lncRNA genes at
six neonatal diabetes loci and in HNF1A, the most common
monogenic diabetes locus (Bell and Polonsky, 2001). Most
such lncRNAs run antisense from the coding gene. Antisense
transcripts have been shown to control the transcription of
protein-coding genes in cis (Wilusz et al., 2009; Xu et al.,
2011). Antisense lncRNAs identified in this study are thus candi-
date regulators of protein-coding genes implicated in human
b cell monogenic disorders and can be potentially affected by
pathogenic mutations.c.
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Figure 7. Several Human lncRNAs Map to T2D-Associated Loci
(A) KCNQ1OT1 and HI-LNC45 are dysregulated in islets from T2D patients. Islet LncRNAs and control mRNAs were assessed by qPCR in islets isolated from
19 control and 16 T2D donors. Values are normalized to TBP mRNA and expressed as a fraction of controls. P values represent Mann-Whitney significance test.
(B) Nine T2D-associated loci contain islet lncRNAs mapping within 150 kb of the reported lead SNPs. Six of these loci have been linked to b cell dysfunction
(Dupuis et al., 2010; van de Bunt and Gloyn, 2010; Voight et al., 2010).
(C and D) Islet lncRNAs map to established T2D association signals located near PROX1 and WFS1. The top panel shows T2D association p values for all
analyzed SNPs in the published DIAGRAM genome-wide association meta analysis (Voight et al., 2010) and the combined p value for the ‘‘lead’’ SNP after further
follow up (rs340874, p = 7.2$1010) (rs1801214, p = 3.16$108), which are denoted as purple diamonds. SNP colors indicate LD relationships. RNA-seq and
ChIP-seq is presented in the bottom panel as described in the legend for Figure 2. See also Table S8.
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T2D, a disease caused by abnormal b cell function or growth
(Bell and Polonsky, 2001; McCarthy, 2010). We identified exam-
ples of islet lncRNAs that are dysregulated in T2D. Our findings
also revealed islet-cell lncRNAs as candidates to dissect the
underpinnings of noncoding variants underlying T2D risk. More
generally, these results set the stage for future studies to dissect
the potential role of inherited and acquired defects in lncRNA
genes in human b cell physiology and disease. Several experi-
mental model systems, including mouse genetics coupled with
perturbation studies in human b cells, are now available to
address this challenge.
EXPERIMENTAL PROCEDURES
Pancreatic Islets and Tissues
Human islets were isolated at the University of Virginia, University of Geneva,
University of Lille, and San Raffaele Scientific Institute islet centers (Bucher
et al., 2005). Human islets used for RNA-seq and ChIP-seq were cultured
with CMRL 1066 medium containing 10% fetal calf serum (FCS) before ship-
ment, after which they were cultured for 3 days with RPMI 1640 medium con-
taining 11 mM glucose, supplemented with 10% FCS. For glucose regulation
experiments, human or mouse islets were cultured for 72 hr in RPMI 1640
medium containing 4 or 11 mM glucose. Donor information for nondiabeticCelland diabetic donors is provided in Table S2. Samples were selected based
on islet cell purity, as assessed by dithizone staining, immunofluorescence
analysis, and qPCR analysis of cell-specific mRNAs.
RNA Analysis
RNA was isolated with Trizol (Invitrogen) or RNeasy (QIAGEN). DNase I
treatment and a control lacking reverse transcriptase were performed on
all RNA samples. Quantitative PCR was performed as described based
on SYBR green detection (van Arensbergen et al., 2010). See Table S9 for
oligonucleotide sequences.
miR-Based Knockdown Assays
Lentiviral vectors carrying two miRNA-based shRNAs targeting HI-LNC25 and
five nontargeting control sequences were transduced into the EndoC-b H1
human b cell line (Castaing et al., 2005; Ravassard et al., 2011; Scharfmann
et al., 2008). Oligonucleotide sequences are shown in Table S9. Nontrans-
duced cells were assayed in parallel. Cells were assayed 3 or 7 days post
transduction.
ES Cell Differentiation
Human ES cells were differentiated to pancreatic insulin-producing cells as
described (Kroon et al., 2008).
RNA-Seq and ChIP-Seq
Chromatin immunoprecipitations (ChIP) were performed as described (Boj
et al., 2009), with modifications described in Supplemental ExperimentalMetabolism 16, 435–448, October 3, 2012 ª2012 Elsevier Inc. 445
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Cell-Type Specific Human and Mouse Islet lncRNAsProcedures. ChIP libraries were prepared according to Illumina protocols and
sequencing of single-end reads was performed on a GAIIx system. RNA-seq
was performed from unidirectional and nondirectional cDNA libraries prepared
from PolyA+ or rRNA-depleted pancreatic islet RNA, and sequenced using
GAIIx, HiSeq2000, or SOLiD 4 systems. Nonpancreatic RNA-seq reads were
retrieved from the Illumina human BodyMap2 data set (http://www.ebi.ac.
uk/arrayexpress/browse.html?keywords=E-MTAB-513) and the ENCODE/
LICR Project (Birney et al., 2007). Reads were aligned to the NCBI36/hg18
and NCBI37/mm9 genomes using Bowtie v0.11.3 for ChIP-seq, allowing one
mismatch per read, no multimapping, and no clonal reads. Nondirectional
RNA-seq libraries were mapped with TopHat v1.2.0, and unidirectional
libraries with Bowtie, using parameters described in the Supplemental
Experimental Procedures. The number of uniquely aligned reads, read length,
and sample information are shown in Tables S1 and S7.
LncRNA Characterization and Analysis
Transcriptional units were defined from the RNA-seq alignments and
joined by splice junctions and paired-end mapping to create putative gene
models. Transcriptional units that were expressed at >0.5 RPKMs, with
H3K4me3 enrichment in the 50 region in at least two samples, and either did
not overlap with annotated protein-coding genes or did overlap but were
transcribed in the opposite strand and were assessed for protein-coding
potential and processed through our lncRNA discovery pipeline. To assess
evolutionary sequence conservation human islet lncRNA exon locations or
the same fragments randomized 1000 times in the alignable portion of inter-
genic space were analyzed. Orthologous mouse genomic sequences were
identified with the LiftOver tool from the UCSC browser. Mouse islet RNA-
seq was used to detect transcripts expressed at >0.5 RPKM in orthologus
or randomized control regions. To evaluate islet specificity of lncRNAs, Cluster
3.0 v1.5a was used for hierarchical clustering of transcript expression in islet
cells and 16 nonpancreatic tissues. Furthermore, a score was created that
measures the difference between the average expression in 3 human islet
PolyA+ samples and the average +2 standard deviations in the remaining 16
tissues. MAGENTA (Segre` et al., 2010) was used to evaluate whether lncRNAs
were enriched for association to T2D and related glycemic traits, with adap-
tions described in the Supplemental Experimental Procedures.
Statistical Analysis
Chi-square, Pearson’s r coefficient, and independent 2-group Mann-Whitney
U tests were implementedwith the R statistical package (http://www.r-project.
org). Student’s t test was performed with Microsoft Excel for quantitative PCR
experiments. Error bars in Figures 4–6 represent SEM.
ACCESSION NUMBERS
Data sets have been deposited in the ArrayExpress Archive under accession
number E-MTAB-1294. Islet lncRNAs coordinates are available at http://
www.betacellregulation.net.
SUPPLEMENTAL INFORMATION
Supplemental Information includes nine figures, four tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.cmet.2012.08.010.
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